STARTUP PROFILE

Spark Biomedical

COUNTRY
USA
FOUNDED
2018
CATEGORY
Neuromodulation
Developing FDA-cleared, wearable, non-invasive auricular neurostimulation (Sparrow Ascent) to provide drug-free relief for opioid withdrawal and other conditions.
Visit website →
Neurofounders Insights
$   Funding   -
Series A
MODALITY
Nerve stimulator
FORM FACTOR
External device
INTERFACE DEPTH
Non-invasive
INDICATION
Multi-indication
TARGET USER
Patients
REGULATORY STAGE
FDA cleared (510k)
Spark Biomedical focuses on auricular neurostimulation for opioid withdrawal and related conditions, targeting a clinically urgent and commercially meaningful use case. Its wearable, drug-free positioning is attractive in a category where speed of adoption can matter.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Spark Biomedical